Big Move For Lineage Cell Therapeutics, Inc.
Fri, Apr 16, 2021 at 05:30 PM
Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT) soared at $7.94, a gain of 25.2%. The stock got featured on our News Catalysts scanner on Thu, Apr 15, 2021 at 04:32 PM in the 'BIOTECH' category. From Thu, Apr 01, 2021, the stock recorded 66.67% Up Days and 40.00% Green Days
The stock spiked on Tue, Apr 06, 2021 at $8.53 with a volume of 44M+.
About Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT)
BioTime Inc focuses regenerative medicine technologies in ophthalmology, soft tissue reconstruction, and the local delivery of cells and therapeutics.
Top 10 Gainers:
- General Finance Corporation (GFN:NASDAQ), 55.71%
- Mer Telemanagement Solutions Ltd. (MTSL:NASDAQ), 34.49%
- StoneMor Inc. (STON:NYSE), 31.33%
- TIRX (TIRX:NASDAQ), 30.96%
- INmune Bio, Inc. (INMB:NASDAQ), 26.46%
- Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT), 25.24%
- China Green Agriculture, Inc. (CGA:NYSE), 21.2%
- CLOV (CLOV:NASDAQ), 20%
- Resolute Forest Products Inc. (RFP:NYSE), 16.46%
- TUYA (TUYA:NYSE), 15.16%